Technology2 July 2026
Belantamab Mafodotin Gets First-in-World MHRA Approval in Myeloma
The MHRA has granted first-in-world approval for belantamab mafodotin combination regimens in relapsed myeloma, supported by landmark DREAMM-7 and DREAMM-8 Phase 3 trial data.
Research15 June 2026
Liquid biopsies could reshape NHS cancer screening in 2026
Liquid biopsies NHS pilot tests multi-cancer early detection to reshape screening pathways and achieve 75% Stage I-II cancer diagnosis by 2028.
Technology5 November 2025
From scepticism to alliance: pharmacists as the human interface for AI
Artificial intelligence is moving from pilot projects to practical tools across the NHS. The policy direction is clear, with a shift to community-based care and a focus on prevention, personalisation
Technology24 October 2025
An evidence based review of IQ Doctor assesses the regulatory clinical and ethical position of UK online pharmacies in 2025
The rise of online pharmacy services has redrawn the UK medicines landscape in less than a decade. Digital ordering, remote prescribing, and courier fulfilment now sit alongside the community pharmacy
Technology21 October 2025
The Critical Role of Medical Freezers in Safeguarding Modern Healthcare and Research
]In today’s fast-evolving healthcare and pharmaceutical industries, precision and reliability are non-negotiable. From hospitals and research laboratories to biotech companies and pharmaceutical manuf
Technology20 October 2025
The association between pelvic and rectal prolapse and cancer risk requires careful evaluation
Prolapse describes structural descent caused by failure of regular anatomical support. Pelvic organ prolapse is an organ herniation into or beyond the vagina driven by weakness in the muscles, fascia